Developed by a steering committee of experts with business-building experience across the life sciences industry, this two-day event will bring together key players involved in investing, partnering, licensing, and developing business opportunities in the rapidly growing market for innovative healthcare products.

Peyton Anderson CEO Affinergy, Inc.	James Isbester Principal Isbester & Associates LLP
Robin R. Bostic Vice President, Reimbursement Thoratec Corp.	John Henry "Jack" Linehan, PhD Consulting Professor, Bioengineering Stanford University
Robert B. Chess Chairman Nektar Therapeutics	Teri Louden President The Louden Network Inc.
Angela D. Craig Vice President, Corporate Relations St. Jude Medical Inc.	Zack Lynch Founder and Executive Director Neurotechnology Industry Organization
Genese Kay Dopson Special Counsel Sedgwick, Detert, Moran & Arnold LLP	Allan W. May Chairman and Founder Life Science Angels
Fredrick J. Dotzler Managing Director De Novo Ventures	J. Casey McGlynn Partner Wilson Sonsini Goodrich & Rosati
Melinda Griffith Former Senior Vice President of Law and Licensing Roche Molecular Systems	Sandra J. Miller Managing Director BioDesign Innovation Program, Stanford University
Dale Hagemeyer Research Vice President Gartner	Robert H. O’Holla Vice President, Regulatory Affairs, Medical Devices and Diagnostics Group, Johnson & Johnson
George Hermann Former Manager Fogarty Engineering	Rhall Pope Vice President, R&D Smiths Medical MD Inc.
Martyn W. C. Howgill Executive Director InHealth: The Institute for Health Technology Studies	Kuo Bianchini Tong President and Founder Quorum Consulting
Arthur S. Hsieh JD, PhD Patent Counsel Kyphon Inc.	Josiah N. Wilcox, Ph.D. Vice President and Resident Scholar Science and Technology Medtronic